A point mutation in the amino terminus of TLR7 abolishes signaling without affecting ligand binding. by Iavarone, C, Ramsauer, K, Kubarenko, A, Debasitis, J, Leykin, I, Weber, A, Siggs, O, Beutler, B, Zhang, P, Otten, G, D'Oro, U, Valiante, N, Mbow, M, Visintin, A

The global response to the COVID-19 pandemic: how have immunology societies contributed? by Osier, F, Ting, JPY, Fraser, J, Lambrecht, BN, Romano, M, Gazzinelli, RT, Bortoluci, KR, Zamboni, DS, Akbar, AN, Evans, J, Brown, DE, Patel, KD, Wu, Y, Perez, AB, Pérez, O, Kamradt, T, Falk, C, Barda-Saad, M, Ariel, A, Santoni, A, Annunziato, F, Cassatella, MA, Kiyono, H, Chereshnev, V, Dieye, A, Mbow, M, Mbengue, B, Niang, MDS, Suchard, M